First and second doses of Covishield vaccine provided high level of protection against SARS-CoV-2 infection in highly transmissible settings: results from a prospective cohort of participants residing in congregate facilities in India.
Tenzin TsundueTenzin NamdonTenzin TsewangSonam TopgyalTashi DolmaDekyi LhadonTsering ChoetsoTenzin WoesalTenzin YangkyiAmita GuptaDavid H PetersZorba PasterDawa PhunkyiTsetan Dorji SadutshangRichard E ChaissonKunchok DorjeePublished in: BMJ global health (2022)
Covishield was effective in preventing SARS-CoV-2 infection and reducing disease severity in highly transmissible settings during the second wave of the pandemic driven by the Delta variant.